Skip to main content
. 2021 Oct 12;7(4):368–398. doi: 10.3934/microbiol.2021023

Table 1. Some recent studies using nanomaterials in the biosensor for detecting SARS-CoV-2.

Nanomaterial/nanostructures Detection of molecule Limit of detection Study
Gold nanostructures Spike protein 5 µg·mL–1 [63]
Gold nanostructures Spike protein 80 copies mL−1 in contaminated water [64]
Gold nanostructures anti-SARS-CoV-2 IgG Semi-quantitative [37]
Gold nanostructures RNA 4 copies/µL [65]
Gold nanostructures N gene and E gene 300 copies/µL of E gene; 225 copies/µL of N gene [66]
Gold nanostructures Viral proteins of SARS-CoV-2 trapped in surgical face masks 3 ng mL−1 [62]
Gold nanostructures RNA 50 RNA copies per reaction [67]
Gold nanostructure 16S rRNAs; N gene (Not Reported) [68]
Gold nanostructures anti-SARS-CoV-2 IgG antibodies 3.2 nM [69]
Gold nanostructures N gene 0.18 ng/µL [39]
Gold nanostructures Viral particles Viral loads corresponding to Ct = 36.5 [38]
Gold nanostructures RNA 10 copies/µL [70]
Gold nanostructures anti-SARS-CoV-2 IgM (Not reported) [55]
Gold nanostructures Highly conserved nucleoprotein 250 pg/mL [56]
Gold nanostructures anti-SARS-CoV-2 IgG (Not reported) [57]
Gold nanostructures Volatile organic compounds from breath (Not reported) [58]
Gold Nano star Spike protein and the virus 130 fg/mL for antigen and 8 particles/mL for virus [71]
Gold nanoislands RNA 0.22 pM [44]
Gold nanoisland films RNA 2.98 copies µL−1 [72]
Gold nanostructures and spherical nucleic acid RNA (Not reported) [73]
Gold nanostructures and spherical nucleic acid RNA Six copies of ssDNA per reaction [36]
Gold nanostructures and graphite Spike protein 229 fg mL−1 [74]
Gold and silver nanostructures Spike protein 0.77 fg mL−1 in PBS; 6.07 fg mL−1 in saliva; 7.60 fg mL−1 in serum; and 0.10 pg mL−1 in blood [75]
(Not Reported) SARS-CoV-2 total antibody (Not Reported) [76]
Gold-platinum core-shell nanostructures Subunit S1 of spike protein (S) 11 ng mL−1 [77]
Gold nanostructure (AuNP)-decorated graphene field-effect transistor (G-FET) sensor RNA 0.37 fM in PBS; 2.29 fM in throat swab; and 3.99 fM in serum [50]
Super paramagnetic nanostructures anti-SARS-CoV-2 IgM and IgG 10 ng/mL for IgM and 5 ng/mL for IgG [78]
Lanthanide-doped nanostructures anti-SARS-CoV-2 IgG (Not Reported) [79]
Selenium nanostructures anti-SARS-CoV-2 IgM and IgG 20 ng/mL for IgM and 5 ng/mL for IgG [46]
Au/Ag coated carbon nanotubes Live virus (Not Reported) [41]
Europium-chelate-based fluorescent nanostructures RNA 1,000 TU (transduction units) mL−1 [80]
Ag shell on SiO2 core (SiO2@Ag) anti-SARS-CoV-2 IgM/IgG 1 pg/mL [43]
(Not Reported) Total antibody (IgA, IgM, and IgG) against SARS-CoV-2 (Not Reported) [81]
Cobalt functionalized-TiO2 nanotube RBD domain of S protein ~0.7 nM [47]
Carbon black Spike (S) protein or Nucleocapsid (N) protein 19 ng/mL for S protein; 8 ng/mL for N protein [60]
Carbon nanotubes RNA 6.4 copies/µL in PBS and 9.2 copies/µL in 50% human saliva [48]
Graphene Spike protein 1.6 × 101 pfu/mL in culture medium; 2.42 × 102 copies/mL in clinical samples; 1 fg/mL in phosphate-buffered saline; 100 fg/mL in clinical transport medium [49]
Graphene Spike protein ∼3.75 and ∼1 fg/mL in artificial saliva and phosphate-buffered saline, respectively [82]
Reduced-graphene-oxide Nano flakes Antibodies to spike S1 protein and its receptor-binding-domain (RBD) 2.8 × 10−15 M for spike S1 protein and 16.9 × 10−15 M receptor-binding-domain [51]
Quantum dot Antibodies 17.5 pM for nucleocapsid antibody and 24.4 pM for S1 antibody [83]
Quantum dot Nano beads SARS-CoV-2 total antibody (Not Reported) [84]
Enzyme-DNA hybrid Nano complexes RNA ~8 RNA copies/µL [85]
Streptavidin coated polymer nanostructures ORF1ab and N gene 12 copies per reaction [45]
Aggregation-induced emission (AIE) dye-loaded nanostructure anti-SARS-CoV-2 IgM and IgG 0.236 mL–1 for IgM; 0.125 µg mL–1 for IgG [86]